Supplemental Figure 1

8
C Supplemental Figure 1 A B

description

Supplemental Figure 1. A B. C. Supplemental Figure 2. RWPE-1. DU-145. AR- CaP -M. PC-3. AR- CaP -E. PC-3-ML. 70 kDa. c- myc. 57 kDa. β-actin. 42 kDa. Supplemental Figure 3. A B. Supplemental Figure 4. pPEG -Luc. pAEG -Luc. 24h 48h. - PowerPoint PPT Presentation

Transcript of Supplemental Figure 1

C

Supplemental Figure 1

A B

57 kDa

70 kDa

RWPE

-1

DU-145

PC-3

PC-3

-ML

AR-Ca

P-E

AR-Ca

P-M

c-myc

42 kDaβ-actin

Supplemental Figure 2

A

B

Supplemental Figure 3

PC3-ML PCa-1

PC3-ML PCa-2

PC3-ML PCa-3

Control Ctrl-1

Control Ctrl-2

Control Ctrl-3

PC3-ML PCa-1

PC3-ML PCa-2

PC3-ML PCa-3

PC3-ML PCa-4

Control Ctrl-1

Control Ctrl-2

Control Ctrl-3

pPEG-Luc pAEG-Luc

24h 48h 24h 48h

D V L R D V L R D V L R D V L R

Supplemental Figure 4

Supplemental Figure 5

(Nor

mal

ized

ng

Luc

pDN

A)/

(100

ng g

DN

A)

AE

G-P

rom

trea

ted

PC

a Lu

ngs

Tum

or

PE

G-P

rom

trea

ted

PC

a Lu

ngs

Tum

or

NS

Gross H&E IHC(Anti-Luc)Pathology

In-vivo BLI

Ex-vivo BLI

A

B

C

D

T

Supplemental Figure 6

E

PC3-MLPCa-1

PC3-MLPCa-2

PC3-MLPCa-3

Control Ctrl-1

Control Ctrl-2

Control Ctrl-3

A B

Supplemental Figure 7

A

B

C

L2 L2

L2L1

L3, L4L5

Supplemental Figure 8